13C-aminopyrine breath test accurately predicts long-term outcome of chronic hepatitis C.

@article{Rocco201213CaminopyrineBT,
  title={13C-aminopyrine breath test accurately predicts long-term outcome of chronic hepatitis C.},
  author={Alba Rocco and Germana de Nucci and Giovanna Valente and Debora Compare and Agesilao D'arienzo and Lucia Cimino and Francesco Perri and Gerardo Nardone},
  journal={Journal of hepatology},
  year={2012},
  volume={56 4},
  pages={782-7}
}
BACKGROUND & AIMS Although numerous non-invasive tests are currently available to explore liver function and disease activity in patients with HCV-related chronic diseases, none of these indicate the likelihood of disease progression in the individual patient. We aimed at assessing the prognostic ability of (13)C(2)-aminopyrine breath test ((13)C-ABT) in the prediction of liver fibrosis progression in patients with HCV chronic hepatitis who prospectively entered a long-term follow-up. METHODS… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 38 references

A sevengene signature ( cirrhosis risk score ) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C

JF Schneider, AL Baker, NW Haines, G Hatfield, JL Boyer
Hepatology • 2009

Systematic review: non-invasive methods of fibrosis analysis in chronic hepatitis

JO Smith, RK Sterling
C. Aliment Pharmacol Ther 2009;30:557–576 • 2009

Similar Papers

Loading similar papers…